- Home
- KALA
KALA
KALA BIO Inc.
as of 12-10-2025 3:46pm EST
$0.74
$0.05
-5.85%
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Chart Type:
Time Range:
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 5.1M | IPO Year: | 2017 |
| Target Price: | $31.50 | AVG Volume (30 days): | 21.0M |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.61 - $20.60 | Next Earning Date: | 11-19-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered KALA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 79.87%
79.87%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of KALA BIO Inc. (KALA)
BAKER BROS. ADVISORS LP
Sell
Other
KALA Oct 1, 2025
Avg Cost/Share
$1.38
Shares
513,607
Total Value
$710,729.37
Owned After
46,480
BAKER BROS. ADVISORS LP
Sell
Other
KALA Sep 30, 2025
Avg Cost/Share
$1.60
Shares
216,801
Total Value
$345,992.72
Owned After
46,480
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | KALA | Other | Oct 1, 2025 | Sell | $1.38 | 513,607 | $710,729.37 | 46,480 | |
| BAKER BROS. ADVISORS LP | KALA | Other | Sep 30, 2025 | Sell | $1.60 | 216,801 | $345,992.72 | 46,480 |
Latest KALA BIO Inc. News
KALA Breaking Stock News: Dive into KALA Ticker-Specific Updates for Smart Investing
GlobeNewswire
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
📊
AI Sentiment
Positive
7/10
MT Newswires
Kala Bio Reports $10 Million Direct Stock Offering; Shares Rise
➖
AI Sentiment
Neutral
5/10
GlobeNewswire
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
📊
AI Sentiment
Positive
6/10
Compare KALA vs Leading Stocks
See how KALA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "KALA KALA BIO Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.